MYGN:NASDAQ
Myriad Genetics Inc
US$4,28
0,00%
(0,00) 1 HR
US$4,23
arrow_downward
-1,17% (-0,050)todaySebelum jam perdagangan normal
Tutup: 7 Okt, 16.00.01 GMT-4 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk MYGN...
Pembukaan
US$4,25
Tinggi
US$4,32
Rendah
US$4,12
Kapitalisasi pasar
409,38 jt
Volume rata-rata
2,01 jt
Volume
404,00
Harga tinggi dalam 52 minggu terakhir
US$8,59
Harga rendah dalam 52 minggu terakhir
US$2,74
EPS
-US$1,20
Beta
1,64
Saham beredar
95,65 jt
Jumlah karyawan
3 rb
Pembukaan
US$4,25
Tinggi
US$4,32
Rendah
US$4,12
Kapitalisasi pasar
409,38 jt
Volume rata-rata
2,01 jt
Volume
404,00
Harga tinggi dalam 52 minggu terakhir
US$8,59
Harga rendah dalam 52 minggu terakhir
US$2,74
EPS
-US$1,20
Beta
1,64
Saham beredar
95,65 jt
Jumlah karyawan
3 rb
Artikel berita
Dari sumber web dan partner berita
Simply Wall Street
·
18 jam yang lalu
Why Myriad Genetics Bears Were Right Before The Drop
AD HOC NEWS
·
2 hari yang lalu
Craig-Hallum raises target for Myriad Genetics stock from USD 4.00 to USD 8.00
Profil
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
Tentang Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Karyawan2,7 rb
Didirikan1991
Kantor PusatKota Salt Lake, Utah, Amerika Serikat
Sektor-
Situsmyriad.com